| Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) (NCT04936282) | Fundación Canaria Instituto de Investigación Sanitaria de Canarias | 2022-07-05 |
| BIOtechnology Applied to Renal TRansplantation With IMmunobiogram (NCT05816486) | Biohope Scientific Solutions for Human Health, S.L. | 2022-03-01 |
| Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies (NCT04694573) | Heidelberg University | 2020-12-28 |
| Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection (NCT03955172) | Hospices Civils de Lyon | 2020-12-03 |
| Tacrolimus Pharmacokinetic Subpopulations (NCT04526431) | University Hospital, Grenoble | 2020-07-28 |
| Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples (NCT04369612) | Oslo University Hospital | 2020-04-28 |
| The Microbiota in Kidney Donation and Transplantation (NCT04388930) | Royal Free Hospital NHS Foundation Trust | 2020-03-01 |
| Protocol Biopsies in High-risk Renal Transplant Recipients (NCT04154267) | Hospital de Clinicas de Porto Alegre | 2020-02-01 |
| Using the Speckle Doppler to Quantify Blood Flow in Kidney and Pancreas Grafts (NCT04202237) | Manchester University NHS Foundation Trust | 2019-12-06 |
| AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation (NCT04057742) | University of Wisconsin, Madison | 2019-10-07 |
| Cf-DNA Assay During Treatment of Acute Rejection (NCT04019353) | University of Minnesota | 2019-06-01 |
| MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process (NCT04413916) | University Medical Centre Ljubljana | 2019-01-01 |
| Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation (NCT03511560) | Columbia University | 2018-07-26 |
| Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients (NCT03438773) | California Institute of Renal Research | 2018-07-11 |
| A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation (NCT03611621) | Hansa Biopharma AB | 2018-06-27 |
| Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients (NCT03437577) | University of Minnesota | 2018-05-08 |
| Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant (NCT03380962) | Stanley Jordan, MD | 2018-02-27 |
| Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients (NCT03465397) | ORIOL BESTARD | 2017-11-10 |
| Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis (NCT03487861) | Asan Medical Center | 2017-08-29 |
| MRI in Renal Transplantation (NCT03705091) | NHS Greater Glasgow and Clyde | 2017-04-11 |
| AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation (NCT03005236) | University Hospital Birmingham NHS Foundation Trust | 2017-04-01 |
| Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes (NCT03466775) | Paris Translational Research Center for Organ Transplantation | 2008-01-01 |
| A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression (NCT00166712) | Northwestern University | 2005-04-01 |
| Long-term Outcomes After Conversion to Belatacept (NCT04733131) | Paris Translational Research Center for Organ Transplantation | 2004-01-01 |
| Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation (NCT05388955) | Radboud University Medical Center | 1966-01-01 |